核受体驱动的免疫代谢交叉:以免疫为中心的药理学,准炎症关节
Yang Zhang1, Zhenzhen Pei1, Zhige Wen1
1Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in cell and developmental biology
|February 6, 2026
概括
免疫为中心的药理学准核受体 (NRs) 来管理肥胖和糖尿病等代谢疾病. 这种方法侧重于免疫细胞来减少慢性炎症,提供了一种新的治疗策略.
科学领域:
- 免疫代谢过程中的免疫代谢.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性轻度炎症 (元炎症) 与肥胖,2型糖尿病 (T2DM) 和非酒精性脂肪性肝病 (NAFLD) 有关.
- 目前的代谢疗法往往忽略了由核受体 (NR) 驱动的免疫失调.
- NRs是通过脂肪,肝脏和肠道免疫的免疫代谢交叉的关键调节者.
研究的目的:
- 提出以免疫为中心的药理学作为代谢性疾病的新疗法范式.
- 突出核受体在免疫细胞重编程和代谢炎症中的作用.
- 探索NR介导路径的时空调节策略.
主要方法:
- 关于核受体和免疫代谢相互作用的当前文献的综述.
- 讨论针对NR介导免疫重编程的新生物药物 (例如TREM2激动剂).
- 探索用于组织特异性NR调节的先进传递系统.
- 通过NR-免疫轴分析代谢药物的免疫调节机制.
主要成果:
- 核受体 (NRs) 对于调节代谢性疾病中的免疫表型变化至关重要.
- NRs介导脂肪,肝脏和肠道免疫之间的关键交叉.
- 通过NR调制向免疫细胞提供了一条破坏炎症微环境的途径.
结论:
- 以NR调节为指导的免疫中心药理学代表了代谢性疾病管理的变革性方法.
- 这一战略通过专注于免疫失调,将药理学创新与治疗翻译联系起来.
- 未来的疗法可以利用NR引导的免疫调节来治疗下一代代代谢性疾病.
相关概念视频
Transducer Mechanism: Nuclear Receptors
2.5K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.5K
Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.6K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.6K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.8K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Design of Columns under a Centric Load
564
The design of columns under centric load is a fundamental aspect of structural engineering and is critical for ensuring the stability and integrity of structures. Euler's and Secant's formulas are central to understanding and calculating the critical load and deformation behaviors of columns, providing a basis for safe and effective structural design.
Euler's formula is applicable under the assumption that the column is a perfect, straight, homogenous prism, and it is operating...
Euler's formula is applicable under the assumption that the column is a perfect, straight, homogenous prism, and it is operating...
564
Nuclear Transmutation
20.7K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
20.7K


